New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 13, 2014
06:07 EDTAZN, WFMStocks with implied volatility below IV index mean; WFM AZN
Stocks with implied volatility below IV index mean; Whole Foods (WFM) 29, AstraZeneca (AZN) 21 according to iVolatility.
News For WFM;AZN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 21, 2015
10:58 EDTAZNDeutsche Bank biotech analyst holds an analyst/industry conference call
Subscribe for More Information
07:37 EDTAZNPfizer replaces AbbVie as top global pharma pick at Jefferies
Subscribe for More Information
May 20, 2015
11:51 EDTAZNExpress Scripts' Medco to pay $7.9M to resolve kickback allegations
Medco Health Solutions, a wholly-owned subsidiary of the pharmacy benefit manager Express Scripts Holding Company (ESRX), of Missouri, has agreed to pay the government $7.9M to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act, the Justice Department announced. Medco provides pharmacy benefit management services to clients who receive subsidies under the Medicare Retiree Drug Subsidy program. The settlement resolves allegations that Medco solicited remuneration from AstraZeneca, a pharmaceutical manufacturer, in exchange for identifying Nexium as the “sole and exclusive” proton pump inhibitor on certain of Medco’s prescription drug lists known as formularies. The United States alleged that Medco received some or all of the remuneration from AstraZeneca in the form of reduced prices on the following AstraZeneca drugs: Prilosec, Toprol XL and Plendil. The United States contended that this kickback arrangement between Medco and AstraZeneca (AZN) violated the Federal Anti-Kickback statute, and thereby caused the submission of false or fraudulent claims for Nexium to the Retiree Drug Subsidy Program. In January 2015, the United States and AstraZeneca reached a $7.9M settlement to resolve kickback allegations arising out of the same conduct. This civil settlement resolves a lawsuit filed under the qui tam, or whistleblower, provision of the False Claims Act, which allows private citizens with knowledge of false claims to bring civil actions on behalf of the government and to share in any recovery. The lawsuit was filed by former AstraZeneca employees Paul DiMattia and F. Folger Tuggle, whose share of the settlement has not been determined. The settlement with Medco was the result of a coordinated effort among the Civil Division, the U.S. Attorney’s Office of the District of Delaware and HHS-OIG.
10:42 EDTWFMKroger CEO says consumer spending still 'fragile'
Kroger (KR) CEO W. Rodney McMullen says the company will continue to spend on stores. McMullen said it will be "fascinating" to see how Whole Foods (WFM) customers react to its plans for a smaller, lower-cost format. Kroger's CEO says food inflation has been tracking a 1%-2% and the company expects it to continue at that level. McMullen says Kroger looks at "just about anything that is available" in terms of M&A, but doesn't bid on many things. McMullen is speaking on CNBC.
May 19, 2015
15:05 EDTAZNArdelyx scheduled for end Phase 2 meeting with FDA scheduled in June
Subscribe for More Information
06:02 EDTWFMWhole Foods implied volatility of 18 at lower end of index mean range
Subscribe for More Information
May 18, 2015
07:46 EDTWFMAmerican Express has $850M revenue opportunity with Plenti, says Deutsche Bank
Deutsche Bank estimates the coalition loyalty/rewards program Plenti represents a $750M-$850M annual revenue opportunity for American Express (AXP) over the next 3-5 years. Earnings accretion will take time, but returns on equity are likely "very high," Deutsche says in a research note. The firm believes Plenti is an example of how Amex is leveraging its strengths to mitigate the loss of Costco (COST). It thinks Plenti's next program supplier needs to be a grocery chain, and pegs Whole Foods (WFM) as a good candidate. Deutsche keeps a Buy rating on American Express with a $90 price target.
06:13 EDTAZNAstraZeneca to invest $285M in new biologics manufacturing facility in Sweden
AstraZeneca announced that it plans to invest approximately $285M in a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The new plant will be focused on filling and packaging of protein therapeutics. It is anticipated that the new facility will supply medicines for clinical trial programs of AstraZeneca and MedImmune, the company’s global biologics research and development arm, from the end of 2018, and will deliver finished products for commercial use once fully operational by 2019. Södertälje is currently home to AstraZeneca’s largest global tablets and capsules manufacturing facility and is also a launch platform site for the company, with specialist capabilities on-site that allow large-scale production of new medicines, working closely with the research and development organisation. By locating the new manufacturing plant in Södertälje, the company will combine its expertise in biologics with the well-established culture of operational excellence that exists within the Sweden Operations unit. The planned investment will, subject to relevant approvals by the local authorities, create between 150 and 250 highly skilled new roles at AstraZeneca by 2019. The new manufacturing facility in Sweden will support the progression of drug candidates across the main therapy areas and be aligned with investments being made in the current biologics manufacturing centers, such as the expansion in Frederick, Maryland, announced in November.
06:05 EDTWFMWhole Foods implied volatility of 19 at lower end of index mean range
Subscribe for More Information
May 17, 2015
15:49 EDTAZNAstraZeneca reports Movantik shows 'similar' adverse event rate vs. placebo
Subscribe for More Information
May 15, 2015
09:31 EDTAZNAmerican Thoracic Society to hold a conference
ATS 2015 Conference is being held in Denver on May 15-20.
06:05 EDTWFMWhole Foods implied volatility of 20 at lower end of index mean range
Subscribe for More Information
May 14, 2015
09:22 EDTAZNLeerink pharma/biotech analysts hold an analyst/industry conference call
Subscribe for More Information
06:22 EDTWFMWhole Foods implied volatility of 20 at lower end of index mean range
Subscribe for More Information
05:52 EDTAZNMizuho expects CAR T stocks to be volatile after ASCO abstract
Subscribe for More Information
May 13, 2015
17:24 EDTAZNAstraZeneca to update progress with immuno-oncology pipeline at ASCO
AstraZeneca and MedImmune, the company’s global biologics research and development arm, will demonstrate rapid progress with their combination-focused oncology pipeline at the American Society of Clinical Oncology, or ASCO, Annual Meeting, May 29-June 2. 61 scientific abstracts will be presented at the meeting, reinforcing the significant progress in immuno-oncology through combination therapies and innovative companion diagnostics.
May 10, 2015
14:12 EDTWFMWhole Foods stock unlikely to outperform in near-term, Barron's says
Subscribe for More Information
May 8, 2015
16:36 EDTWFMStocks end week higher as jobs data, M&A boosts shares
Stocks finished the week higher as favorable U.S. jobs data and significant M&A news boosted the major averages. MACRO NEWS: Weekly jobless claims and nonfarm payrolls for April both beat expectations. The U.S. unemployment rate fell to 5.4% from 5.5%. Other U.S. economic data points were mixed, as a services sector index for April beat expectations, while factory orders for March were in-line with the consensus estimate... Fed Chairman Janet Yellen said that high equity valuations could pose potential dangers... In China, exports fell 6.2% and imports slid 16.1% in April, according to government data... In Europe, the Conservative party succeeded in a surprise election victory in the U.K. and David Cameron will return as prime minister. Elsewhere in the region, a report showed that industrial production in Germany unexpectedly declined 0.5% in March. COMPANY NEWS: Yelp (YELP) rallied after Dow Jones reported that the company is looking to sell itself... Bloomberg reported early in the week that Microsoft (MSFT) was considering a bid for software as a service provider Salesforce (CRM). However, Reuters reported today that Microsoft isn't currently interested in buying the cloud company... Agricultural products maker Monsanto (MON) confirmed that it had made a bid to acquire Syngenta (SYT) for 449.00 CHF per share. Switzerland based Syngenta, which develops crop protection and seed products, turned down the offer, which it believes undervalues the company... McDonald's (MCD) said it would restructure its business into four segments, accelerate the pace of its refranchising and reach the top end of its three year $18B-$20B cash return to shareholders target by the end of 2016... Cisco (CSCO) announced that Chuck Robbins would take over as CEO and that John Chambers would assume the role of executive chairman on July 26... Among the companies whose stocks fell following their earnings reports were organic foods supermarket chains Whole Foods (WFM) and Sprouts Farmers Markets (SFM) and accessories designer Kate Spade (KATE). Conversely, the shares of Herbalife (HLF) and data analytics tool provider Tableau (DATA) advanced after their quarterly reports. INDEXES: For the week, the Dow rose 0.9% to 18,191.11, the Nasdaq fell 0.05% to 5,003.55, and the S&P 500 gained 0.36% to 2,116.10.
12:58 EDTWFMOn The Fly: Top stock stories at midday
Subscribe for More Information
11:44 EDTWFMSprouts Farmers Markets tumbles after Q1 results miss expectations, SSS slows
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use